Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

US Pharmaceuticals Ishares ETF (IHE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 406,112,500
  • Market Capitalization, $K 406,113
  • Shares Outstanding, K 2,650
  • 36-Month Beta 1.07
  • Price/Book 3.43
  • Price/Earnings ttm 21.56
  • Annual Dividend & Yield 1.79 (1.17%)
  • Most Recent Dividend 0.396 on 09/26/18
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
149.22 +3.95%
on 11/15/18
161.06 -3.69%
on 12/04/18
+0.36 (+0.23%)
since 11/12/18
3-Month
149.22 +3.95%
on 11/15/18
170.26 -8.89%
on 09/21/18
-11.98 (-7.17%)
since 09/12/18
52-Week
139.28 +11.37%
on 05/03/18
170.26 -8.89%
on 09/21/18
-0.35 (-0.23%)
since 12/12/17

Most Recent Stories

More News
Beaten-Down Pharma ETFs to Buy Post Q3 Results

Despite strong results, the broad market sell-off took the sheen from the pharma ETFs over the past month. These funds have a Zacks ETF Rank #2 (Buy), suggesting solid entry point on beaten down prices....

XPH : 41.67 (+1.19%)
MRK : 78.22 (+1.44%)
JNJ : 148.20 (+1.16%)
IHE : 154.75 (+0.88%)
PJP : 67.72 (+1.32%)
PPH : 60.21 (+1.59%)
PFE : 44.40 (+0.89%)
BMY : 53.71 (+2.44%)
FTXH : 20.88 (+0.24%)
Beaten-Down Pharma ETFs to Buy Post Q3 Results

Despite strong results, the broad market sell-off took the sheen from the pharma ETFs over the past month. These funds have a Zacks ETF Rank #2 (Buy), suggesting solid entry point on beaten down prices....

XPH : 41.67 (+1.19%)
MRK : 78.22 (+1.44%)
JNJ : 148.20 (+1.16%)
IHE : 154.75 (+0.88%)
PJP : 67.72 (+1.32%)
PPH : 60.21 (+1.59%)
PFE : 44.40 (+0.89%)
BMY : 53.71 (+2.44%)
FTXH : 20.88 (+0.24%)
ETF Strategies for the Midterm Elections

Investors should focus on some strategies as to which sector should they take positions or which should be avoided if bipartisan government forms.

TAN : 20.33 (+1.09%)
PPA : 53.87 (+1.87%)
GII : 47.59 (+0.88%)
IHE : 154.75 (+0.88%)
XAR : 85.50 (+2.09%)
IGF : 41.55 (+1.02%)
PPH : 60.21 (+1.59%)
KBE : 40.54 (+1.68%)
XPH : 41.67 (+1.19%)
ITA : 187.19 (+1.77%)
PJP : 67.72 (+1.32%)
ICLN : 8.82 (+1.03%)
KRE : 51.05 (+1.69%)
FTXH : 20.88 (+0.24%)
ETF Strategies for the Midterm Elections

Investors should focus on some strategies as to which sector should they take positions or which should be avoided if bipartisan government forms.

TAN : 20.33 (+1.09%)
PPA : 53.87 (+1.87%)
GII : 47.59 (+0.88%)
IHE : 154.75 (+0.88%)
XAR : 85.50 (+2.09%)
IGF : 41.55 (+1.02%)
PPH : 60.21 (+1.59%)
KBE : 40.54 (+1.68%)
XPH : 41.67 (+1.19%)
ITA : 187.19 (+1.77%)
PJP : 67.72 (+1.32%)
ICLN : 8.82 (+1.03%)
KRE : 51.05 (+1.69%)
FTXH : 20.88 (+0.24%)
Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

AZN : 39.01 (+0.91%)
PJP : 67.72 (+1.32%)
IHE : 154.75 (+0.88%)
PPH : 60.21 (+1.59%)
PFE : 44.40 (+0.89%)
BMY : 53.71 (+2.44%)
Pharma & Biotech ETFs Soar on Trump's Drug Plan

Trump's drug plan went in favor of pharma and biotech companies, which caused these ETFs soaring.

XPH : 41.67 (+1.19%)
PBE : 50.53 (+0.54%)
SBIO : 32.53 (+2.17%)
PTH : 79.65 (+1.93%)
PJP : 67.72 (+1.32%)
IHE : 154.75 (+0.88%)
PPH : 60.21 (+1.59%)
GNRX : 22.68 (+1.43%)
PILL : 27.67 (+3.83%)
SPY : 266.94 (+1.06%)
FTXH : 20.88 (+0.24%)
Pharma & Biotech ETFs Soar on Trump's Drug Plan

Trump's drug plan went in favor of pharma and biotech companies, which caused these ETFs soaring.

XPH : 41.67 (+1.19%)
PBE : 50.53 (+0.54%)
SBIO : 32.53 (+2.17%)
PTH : 79.65 (+1.93%)
PJP : 67.72 (+1.32%)
IHE : 154.75 (+0.88%)
PPH : 60.21 (+1.59%)
GNRX : 22.68 (+1.43%)
PILL : 27.67 (+3.83%)
SPY : 266.94 (+1.06%)
FTXH : 20.88 (+0.24%)
Q1 Earnings Drag Pharma ETFs Down

Pharma ETFs saw terrible trading over the past month as mediocre results failed to boost confidence in the space, pushing many funds to 52-week lows.

XPH : 41.67 (+1.19%)
JNJ : 148.20 (+1.16%)
MRK : 78.22 (+1.44%)
PJP : 67.72 (+1.32%)
IHE : 154.75 (+0.88%)
LLY : 114.80 (+0.26%)
PPH : 60.21 (+1.59%)
PFE : 44.40 (+0.89%)
BMY : 53.71 (+2.44%)
FTXH : 20.88 (+0.24%)
Q1 Earnings Drag Pharma ETFs Down

Pharma ETFs saw terrible trading over the past month as mediocre results failed to boost confidence in the space, pushing many funds to 52-week lows.

XPH : 41.67 (+1.19%)
JNJ : 148.20 (+1.16%)
MRK : 78.22 (+1.44%)
PJP : 67.72 (+1.32%)
IHE : 154.75 (+0.88%)
LLY : 114.80 (+0.26%)
PPH : 60.21 (+1.59%)
PFE : 44.40 (+0.89%)
BMY : 53.71 (+2.44%)
FTXH : 20.88 (+0.24%)
Is SPDR S&P Pharmaceuticals ETF (XPH) a Hot ETF Right Now?

Smart Beta ETF report for XPH

XPH : 41.67 (+1.19%)
JAZZ : 141.04 (+0.47%)
PJP : 67.72 (+1.32%)
IHE : 154.75 (+0.88%)
LLY : 114.80 (+0.26%)
AGN : 152.76 (+2.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade IHE with:

Fund Summary

The iShares U.S. Pharmaceuticals ETF seeks to track the investment results of an index composed of U.S. equities in the pharmaceuticals sector. The Fund seeks investment results that correspond to the price and yield of the Dow Jones U.S. Select Pharmaceuticals Index.

See More

Top 10 Holdings

Key Turning Points

2nd Resistance Point 156.25
1st Resistance Point 154.82
Last Price 154.75
1st Support Level 151.90
2nd Support Level 150.41

See More

52-Week High 170.26
Fibonacci 61.8% 158.43
Fibonacci 50% 154.77
Last Price 154.75
Fibonacci 38.2% 151.11
52-Week Low 139.28

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar